A study looking at how bacteria in the gut affects treatment for pelvic cancer (PELICAN-23)
This study is looking to see if gut bacteria the microbiome affects how well treatment works for certain cancers that started in the pelvis.
Cancer of the anus - the opening to the outside of the body at the end of the bowel. There are several different types of anal cancer.
This study is looking to see if gut bacteria the microbiome affects how well treatment works for certain cancers that started in the pelvis.
This trial is looking at adding pembrolizumab to chemoradiotherapy to improve treatment for anal cancer.
This study is looking at a drug called INCB106385 by itself or with another immunotherapy called retifanlimab (INCMGA00012) for some advanced solid cancers.
This trial is looking at adding retifanlimab to chemotherapy for people with anal cancer.
This study looked at a blood test called a multi cancer early detection (MCED) test. It is also called the Galleri test.
This study is looking at laser treatment for abnormal cells around the anus that could become cancer and how the treatment affects the function of the anus.
When diagnosed at its earliest stage, around all (99%) people with anal cancer will survive their disease for one year or more, compared with more than 1 in 2 (53%) people when the disease is diagnosed at the latest stage.
Since the late 1970s, anal cancer mortality rates have increased by four-fifths (80%) in the UK. Rates in females have more than doubled (121%), and rates in males have increased by almost two-fifths (38%) (2017-2019).
Over the last decade, anal cancer mortality rates have increased by almost two-fifths (38%) in the UK. Rates in females have increased by more than half (52%), and rates in males have remained stable (2017-2019).
This study was for people who had a low level of red blood cells (anaemia) caused by a lack of iron in the body.
Mortality rates for anal cancer in the UK are highest in people aged 90+ (2017-2019).
Each year more than 4 in 10 of all anal cancer deaths (42%) in the UK are in people aged 75 and over (2017-2019).